Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
暂无分享，去创建一个
R. Sullivan | Douglas B. Johnson | I. Osman | G. Long | A. Menzies | M. Carlino | Fei Ye | A. Haydon | E. Davis | J. Mehnert | J. Patrinely | P. Bhave | R. Fan | Amelia Sawyers | Suthee Rapisuwon | M. Palmeri | Rebecca N. Johnson | Aleigha R Lawless | M. Dimitrova | H. Yeoh | Run Fan | Rebecca Johnson | E. J. Davis | Aleigha Lawless | Aleigha R. Lawless